Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
8fpwLgf5gEXMNybw
